Drug intelligence / Profile preview

Freederm

Development stage
Unknown
Lead developer
Diomed Developments
Modality
Small Molecules
Administration
Topical
01

Overview

Freederm is an over-the-counter topical acne treatment developed and manufactured by Diomed Developments Limited. The formulation contains 4% w/w nicotinamide (niacinamide), a form of Vitamin B3, in a gel base. It is specifically indicated for the treatment of mild to moderate inflammatory acne vulgaris, including inflamed papules and pustules. Nicotinamide exerts its therapeutic effect through anti-inflammatory activity, reducing the swelling, redness, and tenderness associated with acne lesions. Additionally, it serves as a precursor to the coenzymes nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are essential for cellular metabolism. The product is intended for twice-daily topical application to affected areas on the face, chest, or back.

Brand names
Freederm
Other names
nicotinamide 4% gel
02

Targets

NAD+ metabolism

Beyond the preview

Go deeper on Freederm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Freederm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call